Events - ExpreS2ion Biotechnologies

Presentation of 2024 second quarter interim results

favorite_border

15 Aug 10:00 AM

Presentation of 2024 second quarter interim results

Virtual

No data found.

Presentation of 2024 first quarter results

ExpreS2ion CEO Bent Frandsen and CFO Keith Alexander will present the 2024 first quarter results and answer investors’ questions. More information and registration can be found on the H.C. Andersen Capital Events website.

H.C. Andersen Life Science Seminar

CEO Bent Frandsen will be participating in the H.C. Andersen Life Science Seminar on June 4th. The event is a good opportunity for us to engage with the life science community and share our latest developments. Bent will…

2024 Rights Issue webinar

ExpreS2ion is carrying out a rights issue with preferential rights for existing shareholders, through which the company is aiming to raise approximately SEK 60 million. CEO Bent U. Frandsen and CFO Keith Alexander will present…

ExpreS2ion CEO Bent Frandsen and CFO Keith Alexander will present the 2024 second quarter interim results and answer investors’ questions.